{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:19:33Z","timestamp":1707524373100},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,30]]},"DOI":"10.7759\/cureus.17561","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T12:45:26Z","timestamp":1630327526000},"source":"Crossref","is-referenced-by-count":1,"title":["Catastrophic Antiphospholipid Syndrome Associated With Systemic Lupus Erythematosus Flare With Multiorgan Failure: A Chronicle of Cardiogenic Shock, Renal Failure, Vasculitis-Like Lesions, and Disseminated Intravascular Coagulation"],"prefix":"10.7759","author":[{"given":"Syed Hamza","family":"Bin Waqar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiman","family":"Rehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: International Consensus Statement on Classification Criteria and Treatment Guidelines","volume":"12","author":"Asherson RA","year":"2003","unstructured":"Asherson RA, Cervera R, de Groot PG, et al.. Catastrophic antiphospholipid syndrome: International Consensus Statement on Classification Criteria and Treatment Guidelines. Lupus. 2003, 12:530-4. 10.1191\/0961203303lu394oa","journal-title":"Lupus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.02.008","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \"CAPS Registry\"","volume":"32","author":"Cervera R","year":"2009","unstructured":"Cervera R, Bucciarelli S, Plas\u00edn MA, et al.. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \"CAPS Registry\". J Autoimmun. 2009, 32:240-5. 10.1016\/j.jaut.2009.02.008","journal-title":"J Autoimmun"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.014175","article-title":"Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients","volume":"63","author":"Cervera R","year":"2004","unstructured":"Cervera R, Asherson RA, Acevedo ML, et al.. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis. 2004, 63:1312-7. 10.1136\/ard.2003.014175","journal-title":"Ann Rheum Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.09.010","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry","volume":"15","author":"Rodr\u00edguez-Pint\u00f3 I","year":"2016","unstructured":"Rodr\u00edguez-Pint\u00f3 I, Moitinho M, Santacreu I, Shoenfeld Y, Erkan D, Espinosa G, Cervera R. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry. Autoimmun Rev. 2016, 15:1120-4. 10.1016\/j.autrev.2016.09.010","journal-title":"Autoimmun Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2006.06.006","article-title":"Laboratory studies on pathophysiology of the catastrophic antiphospholipid syndrome","volume":"6","author":"Espinosa G","year":"2006","unstructured":"Espinosa G, Bucciarelli S, Cervera R, G\u00f3mez-Puerta JA, Font J. Laboratory studies on pathophysiology of the catastrophic antiphospholipid syndrome. Autoimmun Rev. 2006, 6:68-71. 10.1016\/j.autrev.2006.06.006","journal-title":"Autoimmun Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14192","article-title":"McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome [IN PRESS]","author":"Legault K","year":"2018","unstructured":"Legault K, Schunemann H, Hillis C, et al.. McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome [IN PRESS]. J Thromb Haemost. 2018, 10.1111\/jth.14192","journal-title":"J Thromb Haemost"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key082","article-title":"The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients","volume":"57","author":"Rodr\u00edguez-Pint\u00f3 I","year":"2018","unstructured":"Rodr\u00edguez-Pint\u00f3 I, Espinosa G, Erkan D, Shoenfeld Y, Cervera R. The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients. Rheumatology (Oxford). 2018, 57:1264-70. 10.1093\/rheumatology\/key082","journal-title":"Rheumatology (Oxford)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.05.004","article-title":"Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab","volume":"12","author":"Berman H","year":"2013","unstructured":"Berman H, Rodr\u00edguez-Pint\u00f3 I, Cervera R, et al.. Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab. Autoimmun Rev. 2013, 12:1085-90. 10.1016\/j.autrev.2013.05.004","journal-title":"Autoimmun Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000290","article-title":"Eculizumab induces sustained remission in a patient with refractory primary catastrophic antiphospholipid syndrome","volume":"21","author":"Zikos TA","year":"2015","unstructured":"Zikos TA, Sokolove J, Ahuja N, Berube C. Eculizumab induces sustained remission in a patient with refractory primary catastrophic antiphospholipid syndrome. J Clin Rheumatol. 2015, 21:311-3. 10.1097\/RHU.0000000000000290","journal-title":"J Clin Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/66399-catastrophic-antiphospholipid-syndrome-associated-with-systemic-lupus-erythematosus-flare-with-multiorgan-failure-a-chronicle-of-cardiogenic-shock-renal-failure-vasculitis-like-lesions-and-disseminated-intravascular-coagulation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:30Z","timestamp":1707507270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/66399-catastrophic-antiphospholipid-syndrome-associated-with-systemic-lupus-erythematosus-flare-with-multiorgan-failure-a-chronicle-of-cardiogenic-shock-renal-failure-vasculitis-like-lesions-and-disseminated-intravascular-coagulation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.17561","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,30]]}}}